Hyperfine (HYPR) Revenue & Revenue Breakdown
Hyperfine Revenue Highlights
Latest Revenue (Y)
$11.03M
Latest Revenue (Q)
$3.64M
Main Geography (Y)
Non-US
Hyperfine Revenue by Period
Hyperfine Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $11.03M | 61.90% |
| 2022-12-31 | $6.81M | 355.48% |
| 2021-12-31 | $1.50M | 408.84% |
| 2020-12-31 | $294.00K | 100.00% |
| 2019-12-31 | - | - |
Hyperfine generated $11.03M in revenue during NA 2023, up 61.90% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Hyperfine Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $3.64M | 0.33% |
| 2024-06-30 | $3.63M | 10.20% |
| 2024-03-31 | $3.29M | 22.67% |
| 2023-12-31 | $2.69M | 15.28% |
| 2023-09-30 | $2.33M | -31.09% |
| 2023-06-30 | $3.38M | 28.31% |
| 2023-03-31 | $2.63M | 85.04% |
| 2022-12-31 | $1.42M | -39.35% |
| 2022-09-30 | $2.35M | 53.16% |
| 2022-06-30 | $1.53M | 1.59% |
| 2022-03-31 | $1.51M | 246.10% |
| 2021-12-31 | $436.00K | 17.52% |
| 2021-09-30 | $371.00K | 3.63% |
| 2021-06-30 | $358.00K | 8.16% |
| 2021-03-31 | $331.00K | 59.90% |
| 2020-12-31 | $207.00K | 459.46% |
| 2020-09-30 | $37.00K | 48.00% |
| 2020-06-30 | $25.00K | - |
| 2020-03-31 | $25.00K | - |
Hyperfine generated $3.64M in revenue during Q3 2024, up 0.33% compared to the previous quarter, and up 107.75% compared to the same period a year ago.
Hyperfine Revenue Breakdown
Hyperfine Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 |
|---|---|---|---|---|---|
| Service | $610.00K | $591.00K | $602.00K | $114.00K | - |
| Product | $3.03M | $2.70M | $1.73M | $2.81M | - |
Latest
Hyperfine's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (83.26%), and Service (16.74%).
Hyperfine Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Non-US | $4.36M | $2.54M | - |
| AUSTRALIA | - | - | $78.00K |
Latest
Hyperfine's latest annual revenue breakdown by geography, as of Dec 23: Non-US (100.00%).
Quarterly Revenue by Country
| Country | Sep 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 |
|---|---|---|---|---|---|---|---|---|---|
| Non-US Countries | $1.16M | $2.43M | $65.00K | $2.90M | $1.03M | $784.00K | $561.00K | - | - |
| Service | - | - | - | - | $114.00K | - | - | - | - |
| Non-US | - | - | - | - | - | $591.00K | - | - | - |
| Canada and Pakistan | - | - | - | - | - | - | - | - | $509.00K |
Latest
Hyperfine's latest quarterly revenue breakdown by geography, as of Sep 24: Non-US Countries (100.00%).
Hyperfine Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PAVM | PAVmed | $2.45B | $979.00M |
| ITGR | Integer | $1.60B | $746.27M |
| LIVN | LivaNova | $1.15B | $318.11M |
| INGN | Inogen | $315.66M | $88.83M |
| ANIK | Anika Therapeutics | $166.66M | $38.75M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $132.58M | $30.34M |
| LUNG | Pulmonx | $68.67M | $20.39M |
| IRMD | IRadimed | $65.56M | $18.33M |
| NPCE | NeuroPace | $65.42M | $21.06M |
| APYX | Apyx Medical | $52.35M | $16.02M |
| OSA | ProSomnus | $27.65M | $7.46M |
| HYPR | Hyperfine | $11.03M | $3.64M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |